Press release, July 20, 2020: A double-blind, placebo-controlled trial conducted in the United Kingdom evaluated

Rationale

Clinical Data for COVID-19

Interferon Beta-1a

Combination of Interferon Beta-1b, Lopinavir/Ritonavir, and Ribavirin in the Treatment of Hospitalized Patients With COVID-19

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store